Kenvue up after report TOMS Capital pushing for sale, separation

Shares of consumer health co Kenvue KVUE.N rise 1.20% to $23.60 premarket

TOMS Capital Investment Management has taken a stake in KVUE and is pushing for changes, Bloomberg News reported on Sunday

The New York-based hedge fund is urging KVUE to consider a full sale or separation of some assets, the report said according to people with knowledge of the matter

The size of TOMS' stake could not immediately be learned, the report added

Earlier this month, KVUE settled the proxy fight with activist Starboard and appointed three directors

Up to last close, stock up ~9% YTD